Most recently, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor functions as being a scavenger https://williamm626mhq4.blog2freedom.com/profile